US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PepGen Inc.

1.45

-0.0500-3.33%

Volume:172.44K

Turnover:250.33K

Market Cap:47.45M

PE:-0.46

High:1.50

Open:1.50

Low:1.42

Close:1.50

Loading ...

Overview Company News Filings

PepGen Announces Positive Initial Results, Including Robust Splicing Correction, From Ongoing Freedom-Dm1 Trial in Patients With Dm1

THOMSON REUTERS

PepGen Inc - Pgn-Edodm1 Shows Favorable Emerging Safety Profile

THOMSON REUTERS

PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1

Analysts Offer Insights on Healthcare Companies: Pro Medicus Limited (OtherPMCUF), PepGen Inc. (PEPG) and Idexx Laboratories (IDXX)

PepGen price target lowered to $16 from $26 at H.C. Wainwright

PepGen Inc. (PEPG) Gets a Buy from Stifel Nicolaus

PepGen Inc : H.c. Wainwright Cuts Target Price to $16 From $26

THOMSON REUTERS

PepGen announces CONNECT program updates

PepGen Announces CONNECT Program Updates

All You Need to Know About PepGen (PEPG) Rating Upgrade to Buy

Wedbush Cuts Price Target on PepGen to $8 From $12, Maintains Outperform Rating

MT Newswires Live

PepGen clinical hold likely to be resolved quickly, says Leerink

BofA Securities Downgrades PepGen to Underperform

MT Newswires Live

BofA downgrades PepGen to Underperform after clinical hold

PepGen downgraded to Underperform from Neutral at BofA

PepGen Shares Fall 37.2% on Receiving Clinical Hold Notice From US FDA for Mid-Stage Muscle Disorder Trial

THOMSON REUTERS

BUZZ-PepGen falls on clinical hold notice from FDA for mid-stage muscle disorder trial

Corrected-PepGen Shares Fall 18.8% Premarket on Receiving Clinical Hold Notice From US FDA for Mid-Stage Muscle Disorder Study (Adds Dropped Word "Premarket")

THOMSON REUTERS

PepGen Receives FDA Clinical Hold in Trial of Potential Duchenne Muscular Dystrophy Treatment; Shares Fall

MT Newswires Live

PepGen Shares Fall 18.8% on Receiving Clinical Hold Notice From US FDA for Mid-Stage Muscle Disorder Study

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PEPG/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PEPG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PEPG\",,,,,undefined,":{"symbol":"PEPG","market":"US","secType":"STK","nameCN":"PepGen Inc.","latestPrice":1.45,"timestamp":1749672000000,"preClose":1.5,"halted":0,"volume":172441,"delay":0,"floatShares":12870445,"shares":32720943,"eps":-3.135021,"marketStatus":"Pre-Mkt","change":-0.05,"latestTime":"06-12 05:26:40 EDT","open":1.5,"high":1.5,"low":1.42,"amount":250331.8064714,"amplitude":0.053333,"askPrice":1.84,"askSize":100,"bidPrice":0.8688,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.135021,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749735000000},"marketStatusCode":1,"adr":0,"listingDate":1651809600000,"exchange":"NASDAQ","adjPreClose":1.45,"postHourTrading":{"tag":"盘后","latestPrice":1.53,"preClose":1.45,"latestTime":"19:54 EDT","volume":743,"amount":1086.75,"timestamp":1749686094362},"volumeRatio":1.3095239890415098,"impliedVol":1.1026,"impliedVolPercentile":0.5474},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PEPG\",,,,,undefined,":{"symbol":"PEPG","floatShares":12870445,"roa":"-40.84%","roe":"-75.45%","lyrEps":-2.849026,"volumeRatio":1.3095239890415098,"shares":32720943,"dividePrice":0,"high":1.5,"amplitude":0.053333,"preClose":1.5,"low":1.42,"week52Low":0.8801,"pbRate":"0.52","week52High":19.298,"institutionHeld":0,"latestPrice":1.45,"eps":-3.135021,"divideRate":0,"volume":172441,"delay":0,"ttmEps":-3.135021,"open":1.5,"prevYearClose":3.79,"prevWeekClose":1.5,"prevMonthClose":1.46,"prevQuarterClose":1.405,"fiveDayClose":1.51,"twentyDayClose":1.53,"sixtyDayClose":2.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PEPG\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2513474068","title":"PepGen Announces Positive Initial Results, Including Robust Splicing Correction, From Ongoing Freedom-Dm1 Trial in Patients With Dm1","url":"https://stock-news.laohu8.com/highlight/detail?id=2513474068","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513474068?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398451,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nFWN3PF146:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2513406737","title":"PepGen Inc - Pgn-Edodm1 Shows Favorable Emerging Safety Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2513406737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513406737?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398451,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nFWN3PF146:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2513474019","title":"PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1","url":"https://stock-news.laohu8.com/highlight/detail?id=2513474019","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513474019?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398400,"startTime":"0","endTime":"0","summary":"– Significant mean splicing correction of 29.1% following a single dose of PGN-EDODM1 at 10 mg/kg –。BOSTON, February 24, 2025----PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced initial positive clinical data from the 5 and 10 mg/kg dose cohorts in the ongoing FREEDOM-DM1 Phase 1 trial investigating PGN-EDODM1 in myotonic dystrophy type 1 .PGN-EDODM1 was observed to have a favorable emerging safety profile in the 5 and 10 mg/kg cohorts through the data cut-off date of December 3, 2024, which has continued through the date of this release. There were no adverse events related to electrolytes","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pepgen-announces-positive-initial-results-120000624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2508795481","title":"Analysts Offer Insights on Healthcare Companies: Pro Medicus Limited (OtherPMCUF), PepGen Inc. (PEPG) and Idexx Laboratories (IDXX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2508795481","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508795481?lang=en_us&edition=fundamental","pubTime":"2025-02-04 15:00","pubTimestamp":1738652429,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pro Medicus Limited (PMCUF – Research Report), PepGe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pro-medicus-limited-otherpmcuf-pepgen-inc-pepg-and-idexx-laboratories-idxx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pro-medicus-limited-otherpmcuf-pepgen-inc-pepg-and-idexx-laboratories-idxx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1941712264.USD","LU1941712348.USD","PEPG","BK4137","LU0690374961.EUR","LU2404859741.USD","BK4139","LU2404859667.USD","HCSG","BK4567","BK4082","BK4588","LU1291159041.SGD","BK4504","IDXX","GB00B4LPDJ14.GBP","BK4585","LU0690374615.EUR","GB00B4QBRK32.GBP","LU1989771016.USD","LU0170899867.USD"],"gpt_icon":0},{"id":"2507647567","title":"PepGen price target lowered to $16 from $26 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2507647567","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507647567?lang=en_us&edition=fundamental","pubTime":"2025-01-30 20:21","pubTimestamp":1738239677,"startTime":"0","endTime":"0","summary":"H.C. Wainwright lowered the firm’s price target on PepGen (PEPG) to $16 from $26 and keeps a Buy rating on the shares after the company shared the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pepgen-price-target-lowered-to-16-from-26-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pepgen-price-target-lowered-to-16-from-26-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2507647379","title":"PepGen Inc. (PEPG) Gets a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2507647379","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507647379?lang=en_us&edition=fundamental","pubTime":"2025-01-30 20:18","pubTimestamp":1738239483,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on PepGen Inc. (PEPG – Research Report) today and set a price target of $17.00. The co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pepgen-inc-pepg-gets-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pepgen-inc-pepg-gets-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4127","SF","PEPG"],"gpt_icon":0},{"id":"2507642257","title":"PepGen Inc : H.c. Wainwright Cuts Target Price to $16 From $26","url":"https://stock-news.laohu8.com/highlight/detail?id=2507642257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507642257?lang=en_us&edition=fundamental","pubTime":"2025-01-30 20:17","pubTimestamp":1738239434,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nFWN3OQ1D8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2507665219","title":"PepGen announces CONNECT program updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2507665219","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507665219?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:21","pubTimestamp":1738185707,"startTime":"0","endTime":"0","summary":"PepGen (PEPG) “provided recent updates on its CONNECT clinical program investigating PGN-EDO51 in Duchenne muscular dystrophy for patients amenable...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pepgen-announces-connect-program-updates?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pepgen-announces-connect-program-updates?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2507966545","title":"PepGen Announces CONNECT Program Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2507966545","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507966545?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:05","pubTimestamp":1738184700,"startTime":"0","endTime":"0","summary":"BOSTON, January 29, 2025----PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today provided recent updates on its CONNECT clinical program investigating PGN-EDO51 in Duchenne muscular dystrophy  for patients amenable to an exon-51 skipping approach.CONNECT2 will enroll boys and young men amenable to exon 51 skipping and its endpoints include safety and tolerability, dystrophin production, exon skipping, and functional outcome measures. In December, the Company announced that it had received a clinical hold notice from the US Food and Drug Administration  regarding its Investigational New Drug application to initiate the CONNECT2 clinical trial in the US, which was previously authorized to proceed by the UK’s Medicines and Healthcare products Regulatory Agency . The Company is working with the FDA to address its questions regarding","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pepgen-announces-connect-program-updates-210500294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2502238704","title":"All You Need to Know About PepGen (PEPG) Rating Upgrade to Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2502238704","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502238704?lang=en_us&edition=fundamental","pubTime":"2025-01-09 01:00","pubTimestamp":1736355610,"startTime":"0","endTime":"0","summary":"PepGen, Inc.  could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 . This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.As such, the Zacks rating upgrade for PepGen is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/know-pepgen-pepg-rating-upgrade-170010304.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PEPG"],"gpt_icon":0},{"id":"2492164318","title":"Wedbush Cuts Price Target on PepGen to $8 From $12, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2492164318","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492164318?lang=en_us&edition=fundamental","pubTime":"2024-12-17 02:34","pubTimestamp":1734374045,"startTime":"0","endTime":"0","summary":"PepGen (PEPG) has an average rating of overweight and mean price target of $14.80, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PEPG"],"gpt_icon":0},{"id":"2492643560","title":"PepGen clinical hold likely to be resolved quickly, says Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2492643560","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492643560?lang=en_us&edition=fundamental","pubTime":"2024-12-17 02:20","pubTimestamp":1734373224,"startTime":"0","endTime":"0","summary":"PepGen (PEPG) announced that the FDA has placed a clinical hold on the Phase 2 CONNECT2-EDO51 study of PGN-EDO51 in Duchenne muscular dystrophy, wh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pepgen-clinical-hold-likely-to-be-resolved-quickly-says-leerink?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pepgen-clinical-hold-likely-to-be-resolved-quickly-says-leerink?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2492617568","title":"BofA Securities Downgrades PepGen to Underperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2492617568","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492617568?lang=en_us&edition=fundamental","pubTime":"2024-12-17 01:33","pubTimestamp":1734370384,"startTime":"0","endTime":"0","summary":"PepGen (PEPG) has an average rating of overweight and mean price target of $14.80, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PEPG"],"gpt_icon":0},{"id":"2492612542","title":"BofA downgrades PepGen to Underperform after clinical hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2492612542","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492612542?lang=en_us&edition=fundamental","pubTime":"2024-12-17 01:10","pubTimestamp":1734369008,"startTime":"0","endTime":"0","summary":"BofA downgraded PepGen (PEPG) to Underperform from Neutral with a price target of $3, down from $6, after the FDA placed a clinical hold on the com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bofa-downgrades-pepgen-to-underperform-after-clinical-hold?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bofa-downgrades-pepgen-to-underperform-after-clinical-hold?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2492125486","title":"PepGen downgraded to Underperform from Neutral at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2492125486","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492125486?lang=en_us&edition=fundamental","pubTime":"2024-12-17 01:05","pubTimestamp":1734368716,"startTime":"0","endTime":"0","summary":"BofA downgraded PepGen (PEPG) to Underperform from Neutral with a $3 price target Published first on TheFly – the ultimate source for real-time, ma...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pepgen-downgraded-to-underperform-from-neutral-at-bofa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pepgen-downgraded-to-underperform-from-neutral-at-bofa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2491694140","title":"PepGen Shares Fall 37.2% on Receiving Clinical Hold Notice From US FDA for Mid-Stage Muscle Disorder Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2491694140","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491694140?lang=en_us&edition=fundamental","pubTime":"2024-12-16 22:32","pubTimestamp":1734359568,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NH0GD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2491369142","title":"BUZZ-PepGen falls on clinical hold notice from FDA for mid-stage muscle disorder trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2491369142","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491369142?lang=en_us&edition=fundamental","pubTime":"2024-12-16 22:16","pubTimestamp":1734358595,"startTime":"0","endTime":"0","summary":"BUZZ-PepGen falls on clinical hold notice from FDA for mid-stage muscle disorder trial ** Shares of drug developer PepGen PEPG.O fall 27.4% to $3.40 premarket  ** Co receives clinical hold notice from the US FDA regarding its mid-stage muscle disorder trial ** The FDA indicated they will provide an official clinical hold letter to the company within 30 days- PEPG** The study was testing co's experimental drug, PGN-EDO51, in a 25-week clinical trial in patients with Duchenne muscular dystrophy** Duchenne muscular dystrophy is a condition that causes skeletal and heart muscle weakness that quickly gets worse with time** \"We intend to work closely with the FDA to address their questions on our application to initiate CONNECT2 as expeditiously as possible,\" - PEPG ** Co says it continues to test PGN-EDO51 in the mid-stage trial in the 10 mg/kg group ** Up to last close, stock 31.2% YTD    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nL4N3NH10I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2491713699","title":"Corrected-PepGen Shares Fall 18.8% Premarket on Receiving Clinical Hold Notice From US FDA for Mid-Stage Muscle Disorder Study (Adds Dropped Word \"Premarket\")","url":"https://stock-news.laohu8.com/highlight/detail?id=2491713699","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491713699?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:59","pubTimestamp":1734357562,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nL8N3NH0Y3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2491699934","title":"PepGen Receives FDA Clinical Hold in Trial of Potential Duchenne Muscular Dystrophy Treatment; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2491699934","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491699934?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:53","pubTimestamp":1734357225,"startTime":"0","endTime":"0","summary":"PepGen  said Monday it has received a Food and Drug Administration clinical hold notice for its investigational new drug application to initiate a phase 2 trial of PGN-EDO51, a potential treatment for Duchenne muscular dystrophy.The regulator will send an official clinical hold letter within 30 days, the company said.\"We intend to work closely with the FDA to address their questions on our application to initiate [the trial] as expeditiously as possible,\" said Paul Streck, head of R&D of PepGen.PepGen were down 23% in recent premarket trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2491696018","title":"PepGen Shares Fall 18.8% on Receiving Clinical Hold Notice From US FDA for Mid-Stage Muscle Disorder Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2491696018","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491696018?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:45","pubTimestamp":1734356758,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NH0G3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PEPG"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":86,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PEPG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"PEPG","fiscalQuarterEnding":"2025/03","expectedEps":-0.72,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.92},{"market":"US","date":"2025-02-24","symbol":"PEPG","fiscalQuarterEnding":"2024/12","expectedEps":-0.81,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740373200000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2024-11-07","symbol":"PEPG","fiscalQuarterEnding":"2024/09","expectedEps":-0.87,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.66},{"market":"US","date":"2024-03-06","symbol":"PEPG","fiscalQuarterEnding":"2023/12","expectedEps":-1.01,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709701200000,"reportTimeType":"post","actualEps":-0.82}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PEPG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PEPG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.2,"hold":0,"sell":0.2,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2,"analysts":5,"updateTime":1734408000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PEPG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PEPG","date":"2025-06-11","current":-0.480423,"percent":0.957503,"low":-10.580456,"twenty":-5.968168,"median":-3.832886,"eighty":-1.698652,"high":-0.363325,"avg":-3.900433,"sd":2.301646,"marketCap":49081414},"quantilePoints":[{"date":"2022-05-06","current":-10.580456,"twenty":-10.288242,"median":-9.84992,"eighty":-9.367212,"marketCap":288645421},{"date":"2022-05-13","current":-9.628297,"twenty":-9.817087,"median":-9.763734,"eighty":-9.34265,"marketCap":262669573},{"date":"2022-05-20","current":-9.226092,"twenty":-9.772763,"median":-9.628297,"eighty":-9.232659,"marketCap":251697016},{"date":"2022-05-27","current":-8.930594,"twenty":-9.767838,"median":-9.336904,"eighty":-8.669571,"marketCap":243635546},{"date":"2022-06-03","current":-8.684346,"twenty":-9.766196,"median":-9.205571,"eighty":-8.733596,"marketCap":236917654},{"date":"2022-06-10","current":-9.160426,"twenty":-9.733363,"median":-9.152218,"eighty":-8.728671,"marketCap":249905578},{"date":"2022-06-17","current":-6.915214,"twenty":-9.615164,"median":-9.094708,"eighty":-8.515256,"marketCap":268939605},{"date":"2022-06-24","current":-6.759752,"twenty":-9.562631,"median":-9.000364,"eighty":-7.559814,"marketCap":262893503},{"date":"2022-07-01","current":-5.878796,"twenty":-9.431299,"median":-8.90597,"eighty":-6.828846,"marketCap":228632254},{"date":"2022-07-08","current":-6.892183,"twenty":-9.280267,"median":-8.643305,"eighty":-6.816179,"marketCap":268043886},{"date":"2022-07-15","current":-5.395134,"twenty":-9.229375,"median":-8.544806,"eighty":-6.734417,"marketCap":209822157},{"date":"2022-07-22","current":-6.788541,"twenty":-9.193259,"median":-8.183642,"eighty":-6.38549,"marketCap":264013151},{"date":"2022-07-29","current":-6.448826,"twenty":-9.165351,"median":-7.364369,"eighty":-6.443068,"marketCap":250801297},{"date":"2022-08-05","current":-6.489131,"twenty":-9.15386,"median":-7.047646,"eighty":-6.405066,"marketCap":252368805},{"date":"2022-08-12","current":-4.845367,"twenty":-9.152218,"median":-6.946883,"eighty":-6.325607,"marketCap":246227027},{"date":"2022-08-19","current":-4.706266,"twenty":-9.145651,"median":-6.897941,"eighty":-6.120627,"marketCap":239158309},{"date":"2022-08-26","current":-4.581074,"twenty":-9.065127,"median":-6.854757,"eighty":-5.91104,"marketCap":232796462},{"date":"2022-09-02","current":-4.534707,"twenty":-9.038923,"median":-6.811573,"eighty":-5.653087,"marketCap":230440223},{"date":"2022-09-09","current":-4.590348,"twenty":-8.992977,"median":-6.794299,"eighty":-4.938101,"marketCap":233267710},{"date":"2022-09-16","current":-2.610471,"twenty":-8.943727,"median":-6.719447,"eighty":-4.823111,"marketCap":132656283},{"date":"2022-09-23","current":-2.309084,"twenty":-8.91582,"median":-6.615805,"eighty":-4.590348,"marketCap":117340727},{"date":"2022-09-30","current":-4.210137,"twenty":-8.772996,"median":-6.468979,"eighty":-4.540271,"marketCap":213946546},{"date":"2022-10-07","current":-5.559421,"twenty":-8.659721,"median":-6.420037,"eighty":-4.540271,"marketCap":282513116},{"date":"2022-10-14","current":-5.100387,"twenty":-8.62853,"median":-6.296242,"eighty":-4.566237,"marketCap":259186345},{"date":"2022-10-21","current":-4.349239,"twenty":-8.603905,"median":-6.143658,"eighty":-4.540271,"marketCap":221015265},{"date":"2022-10-28","current":-5.012289,"twenty":-8.534956,"median":-6.077443,"eighty":-4.532853,"marketCap":254709489},{"date":"2022-11-04","current":-4.984469,"twenty":-8.470931,"median":-5.988196,"eighty":-4.540271,"marketCap":253295746},{"date":"2022-11-11","current":-5.134023,"twenty":-8.291991,"median":-5.898949,"eighty":-4.552327,"marketCap":314777227},{"date":"2022-11-18","current":-6.051364,"twenty":-7.809345,"median":-5.878796,"eighty":-4.571801,"marketCap":371021206},{"date":"2022-11-25","current":-5.746868,"twenty":-7.490864,"median":-5.870208,"eighty":-4.584784,"marketCap":352351986},{"date":"2022-12-02","current":-5.758431,"twenty":-7.368983,"median":-5.771921,"eighty":-4.590348,"marketCap":353060944},{"date":"2022-12-09","current":-5.238091,"twenty":-7.334388,"median":-5.758431,"eighty":-4.61075,"marketCap":321157847},{"date":"2022-12-16","current":-5.477062,"twenty":-7.213473,"median":-5.732221,"eighty":-4.667318,"marketCap":335809640},{"date":"2022-12-23","current":-5.789266,"twenty":-7.047646,"median":-5.746868,"eighty":-4.706266,"marketCap":354951498},{"date":"2022-12-30","current":-5.153295,"twenty":-7.031524,"median":-5.693886,"eighty":-4.71183,"marketCap":315958823},{"date":"2023-01-06","current":-5.804684,"twenty":-6.967035,"median":-5.693886,"eighty":-4.734086,"marketCap":355896775},{"date":"2023-01-13","current":-6.166995,"twenty":-6.92673,"median":-5.693397,"eighty":-4.789727,"marketCap":378110784},{"date":"2023-01-20","current":-6.664209,"twenty":-6.917517,"median":-5.707168,"eighty":-4.808273,"marketCap":408595965},{"date":"2023-01-27","current":-6.213247,"twenty":-6.901396,"median":-5.75788,"eighty":-4.816954,"marketCap":380946614},{"date":"2023-02-03","current":-5.928024,"twenty":-6.893335,"median":-5.769995,"eighty":-4.836178,"marketCap":363458991},{"date":"2023-02-10","current":-6.587121,"twenty":-6.88297,"median":-5.781558,"eighty":-4.84444,"marketCap":403869581},{"date":"2023-02-17","current":-6.556286,"twenty":-6.83921,"median":-5.804684,"eighty":-4.849077,"marketCap":401979027},{"date":"2023-02-24","current":-6.47149,"twenty":-6.824881,"median":-5.862986,"eighty":-4.852786,"marketCap":396780003},{"date":"2023-03-03","current":-6.109179,"twenty":-6.819293,"median":-5.878796,"eighty":-4.862987,"marketCap":374565995},{"date":"2023-03-10","current":-5.538732,"twenty":-6.813876,"median":-5.902363,"eighty":-4.871333,"marketCap":339590747},{"date":"2023-03-17","current":-6.822238,"twenty":-6.813876,"median":-5.878796,"eighty":-4.88988,"marketCap":418285054},{"date":"2023-03-24","current":-5.241352,"twenty":-6.804663,"median":-5.882211,"eighty":-4.914918,"marketCap":362198413},{"date":"2023-03-31","current":-4.208913,"twenty":-6.796602,"median":-5.870208,"eighty":-4.852786,"marketCap":290852698},{"date":"2023-04-06","current":-3.957686,"twenty":-6.791996,"median":-5.809194,"eighty":-4.827071,"marketCap":273491907},{"date":"2023-04-14","current":-3.548151,"twenty":-6.78653,"median":-5.796975,"eighty":-4.717394,"marketCap":245191440},{"date":"2023-04-21","current":-4.322481,"twenty":-6.774009,"median":-5.777703,"eighty":-4.590348,"marketCap":298700726},{"date":"2023-04-28","current":-5.062396,"twenty":-6.727508,"median":-5.762285,"eighty":-4.590348,"marketCap":349831822},{"date":"2023-05-05","current":-5.059038,"twenty":-6.673168,"median":-5.746868,"eighty":-4.594705,"marketCap":349599765},{"date":"2023-05-12","current":-5.041307,"twenty":-6.664209,"median":-5.695324,"eighty":-4.617285,"marketCap":338659909},{"date":"2023-05-19","current":-5.292665,"twenty":-6.651757,"median":-5.689053,"eighty":-4.651462,"marketCap":355545340},{"date":"2023-05-26","current":-5.027146,"twenty":-6.627029,"median":-5.6428,"eighty":-4.682483,"marketCap":337708617},{"date":"2023-06-02","current":-5.22186,"twenty":-6.617526,"median":-5.615819,"eighty":-4.706266,"marketCap":350788880},{"date":"2023-06-09","current":-5.80246,"twenty":-6.613923,"median":-5.619674,"eighty":-4.709351,"marketCap":389791847},{"date":"2023-06-16","current":-4.570455,"twenty":-6.602539,"median":-5.600402,"eighty":-4.646407,"marketCap":307029454},{"date":"2023-06-23","current":-3.402174,"twenty":-6.587121,"median":-5.577654,"eighty":-4.590348,"marketCap":228547874},{"date":"2023-06-30","current":-3.455278,"twenty":-6.584038,"median":-5.56064,"eighty":-4.555109,"marketCap":232115218},{"date":"2023-07-07","current":-2.793252,"twenty":-6.569391,"median":-5.550856,"eighty":-4.526361,"marketCap":187642323},{"date":"2023-07-14","current":-2.956104,"twenty":-6.557828,"median":-5.538732,"eighty":-4.44661,"marketCap":198582179},{"date":"2023-07-21","current":-2.821574,"twenty":-6.553974,"median":-5.502116,"eighty":-4.393239,"marketCap":189544907},{"date":"2023-07-28","current":-2.017939,"twenty":-6.547807,"median":-5.477062,"eighty":-4.337232,"marketCap":135559092},{"date":"2023-08-04","current":-2.017939,"twenty":-6.54246,"median":-5.426956,"eighty":-4.319075,"marketCap":135559092},{"date":"2023-08-11","current":-1.819033,"twenty":-6.538589,"median":-5.413033,"eighty":-4.237584,"marketCap":126211799},{"date":"2023-08-18","current":-2.309829,"twenty":-6.537014,"median":-5.39612,"eighty":-4.161181,"marketCap":160265171},{"date":"2023-08-25","current":-1.841342,"twenty":-6.508284,"median":-5.365285,"eighty":-3.959751,"marketCap":127759679},{"date":"2023-09-01","current":-2.162247,"twenty":-6.487797,"median":-5.32819,"eighty":-3.925336,"marketCap":150025346},{"date":"2023-09-08","current":-2.165679,"twenty":-6.480741,"median":-5.297975,"eighty":-3.659632,"marketCap":150263481},{"date":"2023-09-15","current":-2.097036,"twenty":-6.468406,"median":-5.292052,"eighty":-3.522166,"marketCap":145500772},{"date":"2023-09-22","current":-1.887676,"twenty":-6.457799,"median":-5.24042,"eighty":-3.35802,"marketCap":130974508},{"date":"2023-09-29","current":-1.743526,"twenty":-6.448826,"median":-5.22186,"eighty":-3.217961,"marketCap":120972818},{"date":"2023-10-06","current":-1.678316,"twenty":-6.448641,"median":-5.175203,"eighty":-3.007083,"marketCap":116448244},{"date":"2023-10-13","current":-1.935726,"twenty":-6.437033,"median":-5.153295,"eighty":-2.877511,"marketCap":134308405},{"date":"2023-10-20","current":-1.87738,"twenty":-6.41595,"median":-5.138035,"eighty":-2.738733,"marketCap":130260102},{"date":"2023-10-27","current":-1.832762,"twenty":-6.411863,"median":-5.137386,"eighty":-2.672884,"marketCap":127164340},{"date":"2023-11-03","current":-1.760687,"twenty":-6.391319,"median":-5.132844,"eighty":-2.525739,"marketCap":122163496},{"date":"2023-11-10","current":-1.30856,"twenty":-6.383611,"median":-5.099169,"eighty":-2.414802,"marketCap":96921136},{"date":"2023-11-17","current":-1.337497,"twenty":-6.379756,"median":-5.08379,"eighty":-2.30968,"marketCap":99064355},{"date":"2023-11-24","current":-1.440381,"twenty":-6.365109,"median":-5.06793,"eighty":-2.272918,"marketCap":106684690},{"date":"2023-12-01","current":-1.575417,"twenty":-6.353547,"median":-5.060717,"eighty":-2.182362,"marketCap":116686380},{"date":"2023-12-08","current":-2.038396,"twenty":-6.347912,"median":-5.041307,"eighty":-2.155383,"marketCap":150977887},{"date":"2023-12-15","current":-2.279531,"twenty":-6.330776,"median":-5.005334,"eighty":-2.155383,"marketCap":168838048},{"date":"2023-12-22","current":-2.173432,"twenty":-6.314232,"median":-4.961285,"eighty":-2.139706,"marketCap":160979577},{"date":"2023-12-27","current":-2.276316,"twenty":-6.309607,"median":-4.947375,"eighty":-2.145086,"marketCap":168599912},{"date":"2024-01-05","current":-2.517451,"twenty":-6.309607,"median":-4.917622,"eighty":-2.145086,"marketCap":186460073},{"date":"2024-01-12","current":-2.237735,"twenty":-6.293418,"median":-4.901008,"eighty":-2.152448,"marketCap":165742287},{"date":"2024-01-19","current":-2.176647,"twenty":-6.279542,"median":-4.868551,"eighty":-2.149994,"marketCap":161217713},{"date":"2024-01-26","current":-2.228089,"twenty":-6.26387,"median":-4.847686,"eighty":-2.159312,"marketCap":165027880},{"date":"2024-02-02","current":-3.983553,"twenty":-6.236762,"median":-4.817965,"eighty":-2.162863,"marketCap":295049847},{"date":"2024-02-09","current":-6.385761,"twenty":-6.236762,"median":-4.815437,"eighty":-2.164543,"marketCap":472974124},{"date":"2024-02-16","current":-5.971046,"twenty":-6.217872,"median":-4.845367,"eighty":-2.168425,"marketCap":442257448},{"date":"2024-02-23","current":-5.903337,"twenty":-6.211356,"median":-4.854641,"eighty":-2.172721,"marketCap":437242480},{"date":"2024-03-01","current":-7.172872,"twenty":-6.242031,"median":-4.887098,"eighty":-2.174075,"marketCap":531273121},{"date":"2024-03-08","current":-5.652729,"twenty":-6.270849,"median":-4.911053,"eighty":-2.177199,"marketCap":444451496},{"date":"2024-03-15","current":-5.723947,"twenty":-6.25312,"median":-4.95433,"eighty":-2.180142,"marketCap":450051025},{"date":"2024-03-22","current":-6.086065,"twenty":-6.25312,"median":-4.998379,"eighty":-2.183328,"marketCap":478522981},{"date":"2024-03-28","current":-5.798016,"twenty":-6.2473,"median":-5.027146,"eighty":-2.184331,"marketCap":455874834},{"date":"2024-04-05","current":-4.76927,"twenty":-6.220956,"median":-5.034226,"eighty":-2.189508,"marketCap":374988597},{"date":"2024-04-12","current":-5.230148,"twenty":-6.213247,"median":-5.027146,"eighty":-2.189704,"marketCap":411225631},{"date":"2024-04-19","current":-4.879466,"twenty":-6.203794,"median":-5.029888,"eighty":-2.199153,"marketCap":383652857},{"date":"2024-04-26","current":-4.819734,"twenty":-6.166995,"median":-4.998379,"eighty":-2.205583,"marketCap":378956389},{"date":"2024-05-03","current":-5.969241,"twenty":-6.166995,"median":-5.005334,"eighty":-2.208798,"marketCap":469337548},{"date":"2024-05-10","current":-5.495492,"twenty":-6.149416,"median":-5.032629,"eighty":-2.208798,"marketCap":432088536},{"date":"2024-05-17","current":-5.508665,"twenty":-6.148781,"median":-5.053766,"eighty":-2.212013,"marketCap":442494520},{"date":"2024-05-24","current":-5.746768,"twenty":-6.143658,"median":-5.062396,"eighty":-2.217161,"marketCap":461620657},{"date":"2024-05-31","current":-6.598291,"twenty":-6.148908,"median":-5.06793,"eighty":-2.225903,"marketCap":530020909},{"date":"2024-06-07","current":-6.99782,"twenty":-6.205685,"median":-5.084957,"eighty":-2.235806,"marketCap":562113918},{"date":"2024-06-14","current":-7.05432,"twenty":-6.25021,"median":-5.092261,"eighty":-2.239664,"marketCap":566652323},{"date":"2024-06-21","current":-6.779895,"twenty":-6.298815,"median":-5.107245,"eighty":-2.245948,"marketCap":544608640},{"date":"2024-06-28","current":-6.642683,"twenty":-6.31192,"median":-5.123473,"eighty":-2.250945,"marketCap":533586799},{"date":"2024-07-05","current":-6.731467,"twenty":-6.352619,"median":-5.135459,"eighty":-2.255593,"marketCap":540718579},{"date":"2024-07-12","current":-6.981678,"twenty":-6.380527,"median":-5.138193,"eighty":-2.258955,"marketCap":560817231},{"date":"2024-07-15","current":-6.796038,"twenty":-6.383424,"median":-5.139314,"eighty":-2.259598,"marketCap":545905328},{"date":"2024-08-02","current":-4.063901,"twenty":-6.38284,"median":-5.138193,"eighty":-2.260241,"marketCap":326441012},{"date":"2024-08-09","current":-3.2831,"twenty":-6.378985,"median":-5.135459,"eighty":-2.276316,"marketCap":292655523},{"date":"2024-08-16","current":-3.316004,"twenty":-6.360187,"median":-5.114102,"eighty":-2.279531,"marketCap":295588597},{"date":"2024-08-23","current":-3.549989,"twenty":-6.355859,"median":-5.092261,"eighty":-2.279531,"marketCap":316446006},{"date":"2024-08-30","current":-3.381812,"twenty":-6.35354,"median":-5.08379,"eighty":-2.285901,"marketCap":301454743},{"date":"2024-09-06","current":-3.239228,"twenty":-6.352312,"median":-5.06793,"eighty":-2.296807,"marketCap":288744759},{"date":"2024-09-13","current":-3.308692,"twenty":-6.346548,"median":-5.060717,"eighty":-2.307174,"marketCap":294936803},{"date":"2024-09-20","current":-3.418372,"twenty":-6.325973,"median":-5.048713,"eighty":-2.30968,"marketCap":304713713},{"date":"2024-09-27","current":-3.177075,"twenty":-6.31192,"median":-5.029888,"eighty":-2.311389,"marketCap":283204510},{"date":"2024-10-04","current":-3.290412,"twenty":-6.309607,"median":-4.998379,"eighty":-2.327135,"marketCap":293307318},{"date":"2024-10-11","current":-3.162451,"twenty":-6.288022,"median":-4.972877,"eighty":-2.336118,"marketCap":281900922},{"date":"2024-10-18","current":-3.242884,"twenty":-6.276459,"median":-4.924191,"eighty":-2.340714,"marketCap":289070656},{"date":"2024-10-25","current":-3.008899,"twenty":-6.258643,"median":-4.907611,"eighty":-2.384529,"marketCap":268213247},{"date":"2024-10-31","current":-2.584801,"twenty":-6.25021,"median":-4.898921,"eighty":-2.404766,"marketCap":230409193},{"date":"2024-11-08","current":-2.103309,"twenty":-6.231494,"median":-4.879466,"eighty":-2.384804,"marketCap":183480022},{"date":"2024-11-15","current":-1.677727,"twenty":-6.216331,"median":-4.870869,"eighty":-2.323296,"marketCap":146354859},{"date":"2024-11-22","current":-1.614205,"twenty":-6.207575,"median":-4.850004,"eighty":-2.29408,"marketCap":140813583},{"date":"2024-11-29","current":-1.886976,"twenty":-6.189074,"median":-4.840731,"eighty":-2.277602,"marketCap":164608471},{"date":"2024-12-06","current":-2.103698,"twenty":-6.166995,"median":-4.81885,"eighty":-2.254876,"marketCap":183513999},{"date":"2024-12-13","current":-1.928079,"twenty":-6.159963,"median":-4.811645,"eighty":-2.233539,"marketCap":168194002},{"date":"2024-12-20","current":-1.528264,"twenty":-6.149162,"median":-4.753308,"eighty":-2.210084,"marketCap":133316564},{"date":"2024-12-27","current":-1.599259,"twenty":-6.147756,"median":-4.727888,"eighty":-2.200439,"marketCap":139509754},{"date":"2025-01-03","current":-1.408693,"twenty":-6.143658,"median":-4.706266,"eighty":-2.184331,"marketCap":122885928},{"date":"2025-01-10","current":-1.289122,"twenty":-6.143178,"median":-4.693198,"eighty":-2.176004,"marketCap":112455292},{"date":"2025-01-17","current":-0.904254,"twenty":-6.136968,"median":-4.641352,"eighty":-2.163478,"marketCap":78881683},{"date":"2025-01-24","current":-0.728634,"twenty":-6.130009,"median":-4.590348,"eighty":-2.145086,"marketCap":63561687},{"date":"2025-01-31","current":-0.538068,"twenty":-6.121945,"median":-4.575765,"eighty":-2.127223,"marketCap":46937861},{"date":"2025-02-07","current":-0.515649,"twenty":-6.113101,"median":-4.543981,"eighty":-2.103542,"marketCap":44982117},{"date":"2025-02-14","current":-0.452127,"twenty":-6.104554,"median":-4.525434,"eighty":-2.087226,"marketCap":39440841},{"date":"2025-02-21","current":-0.538068,"twenty":-6.09992,"median":-4.492102,"eighty":-2.061071,"marketCap":46937861},{"date":"2025-02-28","current":-0.882881,"twenty":-6.092983,"median":-4.472991,"eighty":-2.017939,"marketCap":79442502},{"date":"2025-03-07","current":-0.879248,"twenty":-6.084519,"median":-4.411834,"eighty":-1.989801,"marketCap":79115578},{"date":"2025-03-14","current":-0.817482,"twenty":-6.072235,"median":-4.394752,"eighty":-1.946683,"marketCap":73557873},{"date":"2025-03-21","current":-0.684868,"twenty":-6.05492,"median":-4.34833,"eighty":-1.929079,"marketCap":61625151},{"date":"2025-03-28","current":-0.584954,"twenty":-6.050431,"median":-4.33982,"eighty":-1.913074,"marketCap":52634744},{"date":"2025-04-04","current":-0.455973,"twenty":-6.048422,"median":-4.324202,"eighty":-1.891794,"marketCap":41028946},{"date":"2025-04-11","current":-0.425091,"twenty":-6.045967,"median":-4.31904,"eighty":-1.87532,"marketCap":38250093},{"date":"2025-04-17","current":-0.44689,"twenty":-6.043655,"median":-4.305274,"eighty":-1.867769,"marketCap":40211637},{"date":"2025-04-25","current":-0.610387,"twenty":-6.03903,"median":-4.222134,"eighty":-1.84839,"marketCap":54923211},{"date":"2025-05-02","current":-0.534088,"twenty":-6.017332,"median":-4.208913,"eighty":-1.830016,"marketCap":48057810},{"date":"2025-05-09","current":-0.493234,"twenty":-6.001276,"median":-4.076181,"eighty":-1.799813,"marketCap":50390252},{"date":"2025-05-16","current":-0.458003,"twenty":-5.986183,"median":-3.983553,"eighty":-1.760687,"marketCap":46790948},{"date":"2025-05-23","current":-0.470814,"twenty":-5.976714,"median":-3.95833,"eighty":-1.751763,"marketCap":48099786},{"date":"2025-05-30","current":-0.53487,"twenty":-5.971046,"median":-3.947361,"eighty":-1.743526,"marketCap":54643974},{"date":"2025-06-06","current":-0.4548,"twenty":-5.969241,"median":-3.923271,"eighty":-1.722933,"marketCap":46463739},{"date":"2025-06-11","current":-0.480423,"twenty":-5.968168,"median":-3.832886,"eighty":-1.698652,"marketCap":49081414}],"updateTime":1749720400209}}}